Volume | 184,495 |
|
|||||
News | - | ||||||
Day High | 0.37 | Low High |
|||||
Day Low | 0.3066 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Calyxt Inc | CLXT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.3243 | 0.3066 | 0.37 | 0.3225 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
187 | 184,495 | $ 0.3348443 | $ 61,777 | - | 0.125 - 1.33 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:08:53 | 3 | $ 0.365 | USD |
Calyxt Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 17.90M | 49.38M | 25.18M | $ 157.00k | $ -139.45k | -0.37 | -0.80 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | -187.50k | 4.30% |
Calyxt News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLXT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.3157 | 0.37 | 0.285 | 0.3331917 | 137,641 | 0.0469 | 14.86% |
1 Month | 0.37 | 0.458 | 0.2518 | 0.3747261 | 222,481 | -0.0074 | -2.0% |
3 Months | 0.135 | 0.5077 | 0.132 | 0.3350137 | 2,049,758 | 0.2276 | 168.59% |
6 Months | 0.2166 | 0.5077 | 0.125 | 0.3048359 | 1,164,601 | 0.146 | 67.41% |
1 Year | 1.18 | 1.33 | 0.125 | 0.3457296 | 1,078,150 | -0.8174 | -69.27% |
3 Years | 3.26 | 12.43 | 0.125 | 1.51 | 482,774 | -2.90 | -88.88% |
5 Years | 17.54 | 22.32 | 0.125 | 2.59 | 328,713 | -17.18 | -97.93% |
Calyxt Description
Calyxt Inc is a plant-based synthetic biology company. The company leverages its proprietary PlantSpring technology platform to engineer plant metabolism to produce high value plant-based chemistries for use in customers materials and products.. The company's diversified offerings are delivered through its proprietary BioFactory production system. The Company operates in the development and commercialization of products derived from plant cells. |